Search research articles
Contact Us
Filters
Showing results (251-260 of 284) with videos related to
Page
of 29
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes
Steven E Lipshultz, Tracie L Miller, Rebecca E Scully, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Eric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Circulation. Heart Failure
|
September 14, 2010
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry
Susan R Foerster, Charles E Canter, Amy Cinar, et al.
Circulation
|
October 2, 2013
Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association
Steven E Lipshultz, M Jacob Adams, Steven D Colan, et al.
Pediatrics
|
November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
Circulation
|
December 25, 2013
Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus
Kunjal Patel, Jiajia Wang, Denise L Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
The Lancet. Oncology
|
September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
Robert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
Circulation Research
|
September 16, 2017
Pediatric Cardiomyopathies
Teresa M Lee, Daphne T Hsu, Paul Kantor, et al.
Page
of 29
Search research articles
Search
Showing results (251-260 of 284) with videos related to
Sort By:
Page
of 29
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes
Steven E Lipshultz, Tracie L Miller, Rebecca E Scully, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Eric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Circulation. Heart Failure
|
September 14, 2010
Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry
Susan R Foerster, Charles E Canter, Amy Cinar, et al.
Circulation
|
October 2, 2013
Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association
Steven E Lipshultz, M Jacob Adams, Steven D Colan, et al.
Pediatrics
|
November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
Circulation
|
December 25, 2013
Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus
Kunjal Patel, Jiajia Wang, Denise L Jacobson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.
The Lancet. Oncology
|
September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
Robert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
Circulation Research
|
September 16, 2017
Pediatric Cardiomyopathies
Teresa M Lee, Daphne T Hsu, Paul Kantor, et al.
Page
of 29